Results 91 to 100 of about 24,144 (221)
Expert consensus using a Delphi methodology proposed definitions of control and remission for allergic rhinitis, conjunctivitis and asthma in the context of allergen immunotherapy. These consensus‐based criteria integrate symptoms, medication use, patient‐reported outcomes and objective measures to support a more structured assessment of treatment ...
Eloína González‐Mancebo +11 more
wiley +1 more source
SARS‐CoV‐2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways
ABSTRACT Background Pain is a common neurological manifestation of COVID‐19, yet the mechanisms by which SARS‐CoV‐2 spike protein fragments contribute to nociceptive processing remain poorly understood. We investigated whether spike‐derived peptides directly activate spinal neuroimmune pathways involved in pain signalling.
Bruno Eduardo Silva +15 more
wiley +1 more source
Inadvertent Intracranial Nasogastric Tube Placement Causing Traumatic Brain Injury in a Neonatal Cat
A 20‐day‐old, 0.26 kg intact female domestic shorthair kitten was presented for evaluation of labored breathing and decreased appetite. Physical examination and thoracic radiographs were consistent with bronchointerstitial pneumonia, and the cat was ...
Riley Shugg +3 more
doaj +1 more source
Rhinorrhea is a predominant symptom of nasal inflammation that comes from the nose's activation glands to produce mucus. Objective: To found out the effectiveness of providing nasal irrigation educational videos on the recovery rate of rhinorrhea ...
Hana Azizatul Fitriah +2 more
doaj +1 more source
ABSTRACT Background and Aims Olfactory dysfunction (OD) is common in COVID‐19, yet its relationship with pulmonary involvement remains inconsistent. We evaluated the association between CT‐based lung involvement and OD in laboratory‐confirmed COVID‐19.
Abdolkarim Ghadimi‐Moghadam +9 more
wiley +1 more source
Abstract Depemokimab is the first ultra‐long‐acting biologic with enhanced interleukin‐5 (IL‐5) binding affinity, high potency, and extended half‐life, enabling twice‐yearly dosing. Depemokimab has demonstrated efficacy and safety in patients with asthma and chronic rhinosinusitis with nasal polyps.
Anders Thorsted +11 more
wiley +1 more source
Abstract Dihydroergotamine (DHE) prescribing information contains a boxed warning regarding the possibility of serious and/or life‐threatening peripheral ischemia with co‐administration of strong cytochrome P450 3A4 (CYP3A4) inhibitors. The effects of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics and safety of nasally administered ...
Detlef Albrecht +2 more
wiley +1 more source
Blue‐Laser Posterior Nasal Neurolysis via Dual Layer Nerve Modulation for Chronic Rhinitis
Blue laser posterior nasal nerve neurolysis combined with inferior turbinate reduction provides superior symptom relief, particularly for rhinorrhea, with excellent safety and tolerability. This dual layer nerve modulation operation offers a promising minimally invasive treatment for medication‐refractory chronic allergic rhinitis.
Lok‐Yee Joyce Li +6 more
wiley +1 more source
Quality of Allergic Rhinitis Content Across Social Media Platforms
ABSTRACT Objectives To assess the quality and engagement of allergic rhinitis‐related short‐form content on social media. Methods A search across TikTok, Instagram Reels, Facebook Reels, and YouTube Shorts was conducted for allergic rhinitis‐related hashtags. Posts were categorized by content category, author, and popularity.
Emily Kwon +6 more
wiley +1 more source

